Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed: 20,548
Companies: 1,769
Drugs tracked: 4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources

Quick answer

TransCon PEG treprostinil

Treprostinil Inhalation Powder

Treprostinil diethanolamine

UB-221

UB-221

UB-421 SC

UB-421 SC(dB4C7C22-6 mAb)

UB-621

UB-921

UI009

UI059

UI059

UI15AML055MT

UIC201602 and co-administration of UIC201601 and UIC201602

UKidney

UNEX-42

USB005 (aclerastide) Ophthalmic Solution

UT-15C

UT-15C SR (treprostinil diethanolamine)

V920

VS-6766

Vaccine/device combination for prevention of HFRS

Venezuelan Equine Encephalitis DNA Vaccine

WX-UK1 in combination with Capecitabine

Frequently asked questions